(Q39091977)

English

Risk of the development of Type 2 diabetes in relation to overall obesity, abdominal obesity and the clustering of metabolic abnormalities in Japanese individuals: does metabolically healthy overweight really exist? The Niigata Wellness Study

scientific article published on 23 December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Risk of the development of Type 2 diabetes in relation to overall obesity, abdominal obesity and the clustering of metabolic abnormalities in Japanese individuals: does metabolically healthy overweight really exist? The Niigata Wellness Study (English)

1 reference

Europe PubMed Central

9 September 2017

type 2 diabetes

0 references

0 references

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Y Heianza

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

K Kato

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

S Kodama

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

N Ohara

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

A Suzuki

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

S Tanaka

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

O Hanyu

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

K Sato

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

23 December 2014

1 reference

Europe PubMed Central

9 September 2017

Diabetic Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

665-672

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

"Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome?"

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Independent impact of body mass index and metabolic syndrome on the risk of type 2 diabetes in Koreans

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Open questions about metabolically normal obesity

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Characterizing the profile of obese patients who are metabolically healthy

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Waist circumference and metabolic risk factors have separate and additive effects on the risk of future Type 2 diabetes in patients with vascular diseases. A cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Impact of body mass index, metabolic health and weight change on incident diabetes in a Korean population

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.12646

21 January 2018

Identifiers

10.1111/DME.12646

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25438871%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39091977&oldid=2076727531"